TEPMETKO

Identification of Tepmetko

No description

Google image searchProduct monograph

Active ingredient

tepotinib (tepotinib hydrochloride), 225 MG

DIN: 02516322

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: EMD SERONO, A DIVISION OF EMD INC., CANADA

Date: 07-OCT-2021

ATC:

Search on Google